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Abstract
In preeclampsia, maternal insulin resistance leads to defective expansion of adipocytes,
enhanced adipocyte lipolysis, up-regulation of very low density lipoprotein synthesis,
maternal hypertriglyceridaemia and the potential for ectopic fat storage. Our aim was to
quantitate and compare the total amount and type of lipid in placenta from pregnancies
complicated with preeclampsia and healthy pregnancies. Quantitative lipid analysis of lipid
extracts from full thickness placental biopsies was carried out by shotgun lipidomics. Pla-
cental lipid profiles from pregnancies complicated by preeclampsia (n = 23) were compared
to healthy pregnancies (n = 68), and placenta from intrauterine growth restriction pregnan-
cies (n = 10) were used to control for gross differences in placental pathology. Placentae
from pregnancies complicated with preeclampsia had higher neutral lipid content than
healthy placentae (40% higher triacyglycerol (P = 0.001) and 33% higher cholesteryl ester
(P = 0.004)) that was specific to preeclampsia and independent of maternal gestation.
Introduction
Preeclampsia (PET) is a leading cause of pregnancy-related maternal and offspring mortality
and morbidity. It occurs in 2–10% of pregnancies and is unique to humans [1]. PET is a multi-
factorial disease with a number of presenting phenotypes caused by a primary defect in tropho-
blast invasion followed by an atypical maternal vascular response resulting in hypertension
and proteinuria [1, 2]. Maternal obesity is a risk factor for PET [3] and an abnormal maternal
metabolic adaptation to pregnancy, reflective of metabolic syndrome, is a key feature of the dis-
ease [4].
Maternal gestational hyperlipidemia is physiological and provides for the energy demands
of the fetus as well as supplying lipid precursors necessary for fetal development [5, 6]. In
healthy pregnancy, mothers store fatty acids in adipose tissue and, as a consequence of the
action of pregnancy hormones, maternal insulin resistance develops in mid to late gestation
[7]. This leads to increased adipocyte lipolysis, up-regulation of very low density lipoprotein
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(VLDL) synthesis by the liver and gestational hypertriglyceridaemia [8]. We have previously
shown that in PET, there is evidence that mothers are less able to expand their adipose tissue
and their adipocytes are more insulin resistant resulting in increased lipolysis[9]. Excessive
lipolysis and reduced capacity to store fatty acids in adipose tissue, such as is seen in type 2 dia-
betes, can lead to ectopic fat accumulation in the liver and other tissues with downstream path-
ological consequences resulting from lipotoxicity [10]. The consequences of inappropriate fatty
acid handling in pregnancy can include vascular dysfunction [4, 11], increased insulin resis-
tance [12] and defects of long chain polyunsaturated fatty acid (PUFA) mobilization [13]. It is
not known to what extent ectopic fat accumulation occurs in PET.
In pregnancy, the placenta is an additional potential site for fat storage. Indeed, lipid storage
droplets in placenta have been observed in a rodent model of PET using histochemical staining
[14]. In humans, higher phospholipid (PL) and cholesterol content of placental tissue and the
decidua basalis have been observed in PET using enzymatic detection [15, 16], as have differ-
ences in lipid mass spectral ion intensity between placentae from healthy and PET pregnancies
[17]. Nevertheless, there are no quantitative data regarding neutral lipid storage in human pla-
centa and there has been no quantitative analysis of placental lipid profile. The aim of this
study was to compare total lipid content, neutral lipid content, and also the lipid profile of pla-
centae from women with healthy pregnancies with those from women with PET. Placentae
from pregnancies complicated by intrauterine growth restriction (IUGR) were also analyzed to
control for the effects of gross placental pathology on lipid composition. This study successfully
achieved the aim to comprehensively assess the lipid content placentae in both healthy and
complicated pregnancy.
Methods
Sample collection and preparation
Women with PET (n = 23), with IUGR (n = 10) and controls with uncomplicated pregnancies
(n = 68) in the third trimester of pregnancy were recruited from the Princess Royal Maternity
Hospital, Glasgow. The study was approved by the Glasgow Royal Infirmary Local Research
Ethics Committee and women gave written informed consent. PET was defined according to
the ISSHP criteria (diastolic blood pressure>110 mmHg on one occasion, or>90 mmHg on
repeated readings, with proteinuria of 0.3g/24 h, or 2+ on dipstick testing, in the absence of
renal disease or infection). IUGRwas defined as an estimated fetal weight<5th percentile for
gestation with associated oligohydramnios (amniotic fluid index<5) and/or abnormal umbili-
cal artery blood flow on Doppler ultrasound. None of the women had a medical history of met-
abolic disease or had suspected fetal anomalies likely to contribute to reduced fetal growth.
Subject characteristics were recorded at time of sampling. Delivery details were recorded from
patient notes. Customised birth weight centiles were calculated using the Gestation Network
Centile Calculator 5.4 (http://www.gestation.net/birthweight_centiles/centile_online.htm). Pla-
cental biopsies were collected at delivery. Biopsies were flash frozen in liquid nitrogen and
stored at -80°C until analyzed.
Blood Pressure and Urinary Protein Measurement
Blood pressure measurements were taken at all routine antenatal visits by a midwife using an
automated sphygmomanometer (A&D digital BP machine) in the left arm in a seated position.
Urinalysis was initially screened using a combiscreen dipstick (Analyticon Biotechnologies)
and, if abnormal on visual screening, confirmed on dipstick reader (Combiscan 100, Analyti-
con Biotechnologies). For women recruited just prior to undergoing Caesarean section, pre-
operative blood pressure was taken using a Dinamap1 (GE Healthcare) in the left arm with
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women in a semi-recumbent position and repeat urinalysis was not performed if a recent mea-
surement in clinic had been negative. In PE women, third trimester blood pressure measure-
ments were taken in the left arm in semi-recumbent position using a Dinamap1.
Chemicals
All solvents were high-performance liquid-chromatography (HPLC) grade or liquid-chroma-
tography mass-spectrometry (LC-MS) grade when available. Methyl-tert butyl ether (MTBE)
was sourced from Sigma (Castle Hill, NSW, Australia) and methanol and chloroform were
obtained from VWR (Murarrie, QLD, Australia). Ammonium acetate was LC-MS grade
(Fluka, Castle Hill, NSW, Australia).
Lipid extraction
Lipid extractionwas performed according to the modification of the method of Tran et al [18].
In brief, 10–30 mg of frozen placental tissue were homogenised in 300 μL methanol using a
bead homogeniser (FastPrep-24, MP Biomedical, SevenHills, NSW, Australia). The homoge-
nate (240 μL) was added to 800 μLMTBE and 50 μL of methanol containing standards listed in
Table A in S1 File. Samples were vortexed overnight at 4°C. Ammonium acetate (200 μL of 150
mM) was added to induce phase separation. The upper organic layer was removed to a new
vial, dried under a stream of nitrogen at 37°C, resuspended in methanol:chloroform (2:1 v/v)
(100 μL per 10 mg tissue) and stored at -20°C until analysis. Extracts were diluted in 30-fold
into methanol:chloroform (2:1 v/v) containing 5 mM ammonium acetate prior to mass spec-
trometric analysis. All samples subjected to ESI-MS were at a concentration below 20 μM, con-
ditions at which ion-suppression effects are minimal [19].
Mass Spectrometry
Mass spectra were acquired using a chip based nano-electrospray ionization source (TriVersa
Nanomate1, Advion, Ithaca, NY, USA) coupled to a hybrid linear ion trap-triple quadrupole
mass spectrometer (MS) (QTRAP1 5500, ABSCIEX, Foster City, CA, USA) according to the
methods of Tran et al. [18] Target lipids and MS aquisition parameters are shown in Table B in
S1 File. An automated method was utilized to cycle all experiments for the duration of each
polarity. Mass spectra were acquired at 200m/z units.s-1 and averaged over 80 cycles. Each
sample was measured once. Data were analyzed with LipidView1 (ABSCIEX) software version
1.2, including smoothing, identification, removal of isotope contribution from lower mass spe-
cies, and correction for isotope distribution. Ionized lipids detectedwithin a mass tolerance of
0.4m/z units with a signal-to-noise ratio (s/n) over 10 were included in the analysis.
Quantification of lipid species was achieved by comparison of the peak area of individual
lipids to their class-specific internal standards after isotope correction. For TAG class lipids,
the signal for all fatty acids at a given mass was summed and the sum-composition TAG spe-
cies (e.g. TAG 48:3) are reported. The fatty acids detected for each sum-composition TAG spe-
cies are shown in Table C in S1 File. In the case of phospholipids (PL), to obtain quantification
of the molecular species of phosphatidylcholine (PC), phosphatidylethanolamine (PE) and
phosphatidylserine (PS), firstly quantification of sum lipid species (headgroup plus total fatty
acid carbon number and double bond number, e.g. PC 34:1) was obtained by comparison to
internal standards in head-group scans in positive mode. Next, negative ion mode precursor
ion scanning for fatty acyl chains was used to determine respective fatty acyl chains for each
lipid species. Ions detected at masses that could be assigned to ether-linked or odd-chain fatty
acids were assumed to be ether-linked species. In cases where more than one isobaricmolecular
species was detected in a class by negative fatty acyl scans, the fractional intensities of each
Lipidomics of Placenta in Preeclampsia
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isobaric species were applied to the quantification obtained in positive mode head group scans.
Lipid classes were determined as the sum total of all molecular lipid species in each class.
Statistics
Data were tested for normality with the Shapiro-Wilk test prior to statistical analysis. Triacyl-
glycerol (TAG), ceramide (Cer) and lipid class data were log-transformed to achieve normality
prior to statistical analysis. Patient characteristics are shown as mean (standard deviations
[SD]) for continuous variables and number (%) for categorical variables. Total levels of the var-
ious lipid classes and species are presented as mean ± standard error of the mean (SEM). PET,
IUGR and healthy control group means were compared using a one-way ANOVA, with
P<0.05 considered significant for demographic and lipid class data and P<0.01 considered sig-
nificant for lipid molecular species data. In the event of a significant result a Tukey post-hoc
test was performed to identify which groups were significantly different. Associations between
variables were assessed using Pearson’s correlation analysis. The impact of potential confound-
ing variables was assessed using general linear models. SPSS v21 (IBM) and Minitab Vs17 were
used for statistical analysis.
Results
Maternal characteristics
Maternal characteristics are shown in Table 1. The PET group had higher (20%) systolic blood
pressure (SBP) and higher (28%) diastolic blood pressure (DBP) than healthy controls. Gesta-
tional age at delivery was lower in PET (8%) and IUGR (8%). Birth weight centile (BWC) were
lower in PET (60%) and IUGR (98%) pregnancies compared to controls. Elective Caesarean
section rate was higher in the healthy pregnancy control group compared to PET.
Placental Lipid Quantification
Shown in Table 2 are the overall lipid class profiles in placental tissue from healthy control,
and complicated pregnancies PET and IUGR.Quantification of lipid molecular species, as well
as lipids that are different between control and PET, are reported in Table D in S1 File.
Table 1. Maternal demographics and plasma lipids.
Variable Control (n = 68) PET (n = 23) IUGR (n = 10) P
Age (years) 30.4 (5.1) 29.5 (5.8) 29.7 (4.9) 0.83
BMI (kg/m2) * 28.9 (6.4) 30.1 (7.4) 24.7 (5.5) 0.068
Primiparous n (%) 27 (40) 14 (61) 4 (40) 0.20
Smoker n (%) 14 (21) 4 (17) 5 (50) 0.099
SBP (mmHg) * 121 (15)1 144 (25)2 113 (4)1 <0.0001
DBP (mmHg) * 71 (10)1 91 (16)2 72 (3)1,2 <0.0001
Gestational age at delivery (days) 275 (9)1 253 (21)2 253 (21)2 <0.0001
BWC 55 (31)1 22 (26)2 1 (2)2 <0.0001
Samples collected when not in labour (%) 51 (75)1 6 (26)2 6 (60)1,2 <0.0001
Fetal sex n (% male) 32 (49) 13 (57) 3 (33) 0.50
BMI, Body mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BWC, birth weight centile;
Values are mean (SD) for continuous variables and number (%) for categorical variables.
ANOVA was used to test for differences among groups (*on log transformed data). Different superscript numbers indicate differences between individual
groups using post hoc Tukey test. Significance level P<0.05.
doi:10.1371/journal.pone.0163972.t001
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PC is the most abundant lipid in placental tissue (~36% of total lipid) from healthy pregnan-
cies, found at 3.2 ± 0.8 μmol/g. Cholesterol was nearly as abundant at 2.9 ± 0.5 μmol/g. Other
PL classes were at substantially lower abundance, with PE, sphingomyelin (SM) and PS found
at 0.93 ± 0.25 μmol/g, 0.71 ± 0.18 μmol/g and 0.36 ± 0.09 μmol/g respectively. Cholesteryl ester
(CE) and TAG were similar in abundance at 0.31 ± 0.10 μmol/g and 0.20 ± 0.11 μmol/g respec-
tively. Low levels of Cer were detected at 0.06 ± 0.02 μmol/g.
Both the neutral storage lipids, CE and TAG, were higher in placenta complicated with PET
compared to healthy controls and IUGR. Both TAG and CE levels were substantially higher in
placenta complicated with PET (40% and 33% respectively) versus healthy controls. These dif-
ferences were retained after correcting for gestational age at delivery. Cholesterol (16%), PC
(18%), and total lipid (18%) were also higher in placenta complicated with PET compared to
healthy controls.
Placental neutral storage lipids
Molecular speciation of the neutral storage lipids CE and TAG was compared between groups
(Fig 1). ThirteenCE species were quantified, with ester-linked carbon chain of lengths from
C14 to C22, shown in Fig 1A. CE is dominated by unsaturated 18 carbon species, with CE 18:1
and 18:2 together representing 63% of total CE in healthy placenta. CE 20:4 and 16:0 are also
abundant, at 11% and 9% respectively. All other speciesmake up 5% or less of total CE. Ten of
the 13 CE species were higher in concentration in PET compared to healthy controls, and three
CE species (16:0, 16:1 and 18:1) were higher in comparison to both healthy and IUGR controls.
A total of 22 TAG lipid species are reported, shown in Fig 1B and 1C. The fatty acids
detected in each TAG molecular species are shown in Table C in S1 File. The most abundant
TAG species are TAG 52:2 and TAG 52:3, each representing nearly 20% of total TAG. TAG
50:1 and 50:2 are also abundant at 11% each of total TAG. Highly unsaturated TAG species
with four or more double bonds were also detected across the entire range of carbon chain
lengths, with these TAG species containing PUFAs 18:2, 20:4 or 22:6 (Table C in 1 File). Similar
to CE, a widespread higher concentration of TAG molecular species was observed in placenta
Table 2. Quantitative comparison of class total lipid profiles in placenta.
Lipid Class (μmol/g tissue) Control (n = 68) PET (n = 23) IUGR (n = 10) P
TAG* 0.20 (0.11)1 0.27 (0.12)2 0.15 (0.05)1 0.001
CE* 0.31 (0.10)1 0.42 (0.16)2 0.28 (0.10)1 0.004
Cholesterol 2.9 (0.5)1 3.4 (0.8)2 3.2 (0.7)1,2 0.006
PC 3.2 (0.8)1 3.7 (1.1)2 3.5 (1.0)1,2 0.025
PE 0.93 (0.25) 1.07 (0.38) 1.01 (0.31) 0.169
PS 0.36 (0.09) 0.40 (0.10) 0.40 (0.13) 0.127
SM 0.71 (0.18) 0.82 (0.26) 0.88 (0.22) 0.014
Total PL 5.2 (1.2)1 6.0 (1.7)2 5.7 (1.6)1,2 0.029
Cer 0.06 (0.02) 0.06 (0.03) 0.06 (0.02) 0.605
Total Lipid 8.6 (1.7)1 10.1 (2.4)2 9.4 (2.4) 1,2 0.006
CE, cholesteryl ester; Cer, ceramides; IUGR, intrauterine growth restriction; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PET, preeclampsia;
PL, phospholipid; PS, phosphatidylserine; SM, sphingomyelin; TAG, triacylglycerol.
Values are mean (SD).
ANOVA was used to test for differences among groups (*on log transformed data). Different superscript numbers indicate differences between individual
groups using post hoc Tukey test. Significance level P<0.05.
doi:10.1371/journal.pone.0163972.t002
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complicated with PET. Of the 22 TAG species detected, 13 were higher in PET compared to
healthy controls and four were higher in PET compared to both IUGR and healthy controls.
Placental membrane lipids
Molecular speciation of the main phospholipids (PC, PE and PS) was compared between
groups. A total of 35 molecular species were detected in PC, including 8 ether-linked species
(Fig 2). The most abundant PC species contained one 16:0 fatty acids (FA) and either a 16:0,
18:1, 18:2, or 20:4 as the second fatty acid. Long chain PCs were less abundant, and were domi-
nated by PC 18:0_20:4 and PC 18:1_20:4. Of the 35 PC species quantified, five species in PET
were at higher concentration relative to healthy controls (16:0_16:1, 16:0_18:1, 16:0_22:5,
18:0_22:6, and O-16:1_16:0) and one species at lower concentration (16:0_18:0), as shown in
Fig 2. The only species that were higher in PET compared to both healthy controls and IUGR
was PC 18:0_22:6.
Fig 1. Storage Lipid Profiles in Placenta. Quantitative comparison of A) triacylglycerol and B) cholesteryl
ester molecular lipid profiles in placenta between control (N = 68), PET (N = 23) and IUGR (N = 10). Values
are shown as the mean of all measurements ± SEM. a = p < 0.01 versus control, b = p < 0.01 versus IUGR.
doi:10.1371/journal.pone.0163972.g001
Lipidomics of Placenta in Preeclampsia
PLOS ONE | DOI:10.1371/journal.pone.0163972 September 29, 2016 6 / 13
PE is less abundant than PC, representing approximately 10% of total lipid, and a total of 50
molecular species were detected, including 19 ether-linked species (Fig 3). PE is dominated by
species containing LC-PUFA, with PE 16:0_20:4 and 18:0_20:4 representing 7% and 15% of
total PE respectively. Six species were detectedwhere both attached fatty acids were PUFA,
including the very-long chain species PE 20:4_22:5 and PE 20:4_22:6. Of the 50 species
detected, four were at higher concentration in placenta compared to healthy controls
(16:0_22:5, 18:1_22:5, O-16:1_22:5, O-18:2_22:5). Interestingly, all these increased species con-
tained the 22:5 fatty acid docosapentaenoic acid (DPA).
PS is the least abundant phospholipid in the placenta; approximately 4% of total lipid. Seven
of the 12 detected PS species contained an 18:0 FA, six of which also contained a PUFA (Fig
Fig 2. Phosphatidylcholine Lipid Profiles in Placenta. Quantitative comparison of phosphatidylcholine
molecular lipid profiles in placenta between control (N = 68), PET (N = 23) and IUGR (N = 10). Values are
shown as the mean of all measurements ± SEM. a = p < 0.01 versus control, b = p < 0.01 versus IUGR.
doi:10.1371/journal.pone.0163972.g002
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4A). Only two PS species differed between groups, with PS 18:0_20:4 39% higher in IUGR than
healthy controls, and PS 18:1_20:4 51% higher in PET than healthy controls.
Ceramidewas the lowest abundance lipid class detected in placental tissue, representing
under 1% of total lipid. SM represented approximately 8% of total lipid. Eight Cer species rang-
ing from 16:0 to 24:2 were identified, with no differences between groups (Fig 4B). SM had
acyl-linkedFA chains ranging from 14:0 to 26:2 (Fig 4C). SM 16:0 was the predominant spe-
cies, comprising 43% of total SM. Other abundant SM species included 18:0, 22:0, 24:0 and
24:1. Of the 15 species of SM detected, two differed between groups, with SM 14:0 20% higher
in PET compared to healthy controls while SM 18:0 was higher in both IUGR (157%) and PET
(113%) compared to healthy controls.
Fig 3. Phosphatidylethanolamine Lipid Profiles in Placenta. Quantitative comparison of
phosphatidylethanolamine molecular lipid profiles in placenta between control (N = 68), PET (N = 23) and
IUGR (N = 10). Values are shown as the mean of all measurements ± SEM. a = p < 0.01 versus control.
doi:10.1371/journal.pone.0163972.g003
Lipidomics of Placenta in Preeclampsia
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Placental cholesterol and total PL concentrations were significantly higher (16% and 17%
respectively) in PET compared to controls with IUGR having intermediate levels (Table 2).
The cholesterol to total PL ratio (an indicator of membrane fluidity) was calculated and was
not different among the 3 groups (control 0.57 (0.10); PET 0.57 (0.08); IUGR 0.57 (0.7)).
Discussion
Presented herein is a comprehensive lipidomics analysis of human placentae with quantitative
comparison between placenta from women with healthy pregnancies and those from women
with PET. This study has directly ascertained for the first time that placental neutral storage
lipid content (TAG and CE) is specifically higher in PET compared to healthy control and
IUGR third trimester placenta. These differences remained after correction for gestational age.
Fig 4. Phosphatidylserine and Sphingolipid Lipid Profiles in Placenta. Lipid Profiles in Placenta.
Quantitative comparison of A) phosphatidylserine B) ceramide and C) sphingomyelin molecular lipid profiles
in placenta between control (N = 68), PET (N = 23) and IUGR (N = 10). Values are shown as the mean of all
measurements ± SEM. a = p < 0.01 versus control.
doi:10.1371/journal.pone.0163972.g004
Lipidomics of Placenta in Preeclampsia
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Others who have not found higher placental TAG content in PET [16] sampled the decidua
basalis in an attempt to characterise acute atherosclerosis, a site of cholesterol deposition,
rather than sampling the full thickness of the placenta. In the results presented here, lipid anal-
ysis was carried out in one random biopsy from each placenta. Sampling location should not
have biased our results as it has been shown that FA composition in placenta is homogenous
across anatomical locations of the placenta [20].
A recent report of 20 pregnant women (10 with early-onset preeclampsia and 10 healthy
pregnancy) does not report similar with the lipid profile nor observe the differences in placenta
complicated with PET that we observed [17]. Notably, that report did not incorporate the stan-
dard practice of internal standards for normalization of lipid extraction and MS ionization for
quantification. Surprisingly, in that report the generally low abundance lipid classes of diacyl-
glyerol and phosphatidylinositol were each reported at over 10% of total lipid signal. Results
for the PET samples were evenmore startling, with over 50% of the total lipid reported as PS,
and over 30% as macrolides and lactone polyketides. As mentioned by the authors, macrolides
and lactone polyketides are not generally found in mammals. It should be noted that plasma
lipidomics were also performed as part of that study, with the reported lipid profile also greatly
at odds with the generally accepted composition of human plasma [21].
Unlike PET, placenta complicated with IUGR had normal levels of neutral storage lipids
(CE and TAG). This may not be surprising since pregnancies complicated with IUGR are char-
acterised by low maternal mobilisation of fat [22]. Cholesterol and PC were higher in PET and
at an intermediate level in IUGR, failing to reach significance perhaps due to low sample size.
The differences in PL, the main components of cellular membranes, between PET and controls
are broadly similar to previously published data using thin layer chromatography [15]. These
alterations in structural lipids may relate to abnormal placental architecture and may be com-
mon to both PET and IUGR. PC and cholesterol are key membrane lipids and changes in pla-
cental content could be related to the recognisedplacental pathologies associated with PET and
IUGR such as reduced numbers of placental villi and abnormal syncytialmembrane structure
[23, 24]. Two SM lipid species were higher in PET and IUGR compared to controls in this
study. Such enrichment in SM was reported in a lipidomic analysis of human placental syncy-
tiotrophoblast microvesicles from abnormal pregnancies, possibly related to microvesicle bio-
genesis and inflammatory and oxidative stress [25].
While previously we have provided indirect evidence for ectopic fat accumulation in PET
[13], here we provide additional evidence that ectopic fat accumulates in PET placenta. Using
direct quantitation we observed a higher concentration of neutral storage lipids (TAG and CE),
typical of those found in intra-cellular lipid droplets associated with ectopic fat storage. Our
data confirm the previously published observation, using non-quantitative histochemical anal-
ysis, of lipid storage droplets in placenta in a rodent model of pre-eclampsia [14] and suggests
that ectopic lipid accumulation in placenta is part of the pathology of PET.
In this study we used low-resolution tandem-MS technique for lipid identification and
quantification [26]. Lipids were identified by nominal ion mass in the respective precursor-ion
or neural-loss scan. Multiple isobaric lipids with different fragmentation profiles are compati-
ble with this workflow as each isobaric lipid is identified in an independent tandem-MS scan.
Quantification was achieved by comparison of signal from each target lipid with an internal
standard. Each lipid class is represented by at least one internal standard; therefore any inter-
class ion suppression is corrected during normalization. However, as only one or two internal
standards were utilized per lipid class, the assumption is made that all lipids within the class
ionize and fragment with the same efficiency. At lipid concentrations below 100 μM these
assumptions hold true for polar lipids [19]. However, TAG quantification may vary across
lipid chain length and saturation [27]. To expand these data, additional TAG internal
Lipidomics of Placenta in Preeclampsia
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standards would improve quantification by correcting for variation in TAG ionization and
fragmentation. In addition, TAG was quantified with neutral-loss scans that are affected by the
position of each acyl group on the TAG glycerol backbone. This results in the inability to quan-
tify the fatty acyl composition of each TAG. The application of LC-MS/MS, high-resolution
MS/MS or MS3 to resolve the TAG molecular lipid species would add valuable insight to the
identity of lipids stored in the placenta in PET.
In summary, the data presented here show higher concentrations of TAG and CE in the pla-
centae from PET pregnancies. These data are the first presentation of a comprehensive, quanti-
tative lipidomics analysis of human placenta and provide insight into the pathology of
placentae from pregnancy complicated by preeclampsia.
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